Antibody profiling and predictive modeling discriminate between Kaposi sarcoma and asymptomatic KSHV infection

PLoS Pathog. 2024 Feb 21;20(2):e1012023. doi: 10.1371/journal.ppat.1012023. eCollection 2024 Feb.

Abstract

Protein-level immunodominance patterns against Kaposi sarcoma-associated herpesvirus (KSHV), the aetiologic agent of Kaposi sarcoma (KS), have been revealed from serological probing of whole protein arrays, however, the epitopes that underlie these patterns have not been defined. We recently demonstrated the utility of phage display in high-resolution linear epitope mapping of the KSHV latency-associated nuclear antigen (LANA/ORF73). Here, a VirScan phage immunoprecipitation and sequencing approach, employing a library of 1,988 KSHV proteome-derived peptides, was used to quantify the breadth and magnitude of responses of 59 sub-Saharan African KS patients and 22 KSHV-infected asymptomatic individuals (ASY), and ultimately to support an application of machine-learning-based predictive modeling using the peptide-level responses. Comparing anti-KSHV antibody repertoire revealed that magnitude, not breadth, increased in KS. The most targeted epitopes in both KS and ASY were in the immunodominant proteins, notably, K8.129-56 and ORF65140-168, in addition to LANA. Finally, using unbiased machine-learning-based predictive models, reactivity to a subset of 25 discriminative peptides was demonstrated to successfully classify KS patients from asymptomatic individuals. Our study provides the highest resolution mapping of antigenicity across the entire KSHV proteome to date, which is vital to discern mechanisms of viral pathogenesis, to define prognostic biomarkers, and to design effective vaccine and therapeutic strategies. Future studies will investigate the diagnostic, prognostic, and therapeutic potential of the 25 discriminative peptides.

MeSH terms

  • Acquired Immunodeficiency Syndrome*
  • Antigens, Viral
  • Epitopes / metabolism
  • Herpesviridae Infections* / complications
  • Herpesvirus 8, Human* / metabolism
  • Humans
  • Nuclear Proteins / metabolism
  • Peptides / metabolism
  • Proteome / metabolism
  • Sarcoma, Kaposi*

Substances

  • Proteome
  • Antigens, Viral
  • Nuclear Proteins
  • Peptides
  • Epitopes